{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Emergence of Cannabinoid Hyperemesis Syndrome

Activity Steps

Purpose of Activity

To provide the latest information on CHS, which includes characteristics, complications, diagnosis, treatment interventions, and patient education.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Recognize the prevalence, phase characteristics, and complications of CHS.
  2. Identify patient assessment points and diagnostic components of CHS and discern signs and symptoms of MUD.
  3. Describe treatment interventions and education for patients with CHS.
Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: NMIE0920B
Published: Sep/Oct 2020
Expires: 9/6/2024
Required Passing Score: 16/20 (80%)
Authors: Meredith Scannell, PhD, MPH, MSN, RN, CEN, CNM, SANE-A
Categories: Acute Care
Specialties: Acute Care